A promising mRNA vaccine-in-the-works could finally knock ou

Tuberculosis kills 1.6 million a year — the second deadliest infectious disease after COVID-19. Using immune cells and mRNA technology, scientists in South Africa are working on a new vaccine.

Related Keywords

South Africa , Stanford , Western Cape , University Of Cape Town , South African , South Africans , Afrigen Biologics , Munyaradzi Musvosvi , Tommy Trenchard , Huang , Africa University Of Cape Town , Gilead Sciences , World Health Organization , African Tb Vaccine Initiative , Pfizer , African Tuberculosis Vaccine Initiative , Tb Research , South African Tuberculosis Vaccine Initiative , Cape Town ,